Study Conduct. 1. The Sponsor with the Institution has designated the Principal Investigator to recruit patients into, and participate in the Study as a Study site. The Institution assures that the Principal Investigator has sufficient authority, competence, and experience in clinical trials, as well as medical and scientific skills to participate in this Study, according to any legal and health applicable requirements. The Institution and the Principal Investigator will use their best efforts to recruit approximately . patients. The parties agree that the increase of the number of patients to be enrolled at the Institution will require written approval from the Sponsor, but not an amendment to this Agreement. Patient enrolment will stop when the total number of patients as specified in the Protocol has been recruited between participating sites.
Appears in 1 contract
Sources: Non Interventional Study Agreement
Study Conduct. 12.1. The Sponsor with the Institution has designated the Principal Investigator to recruit patients into, and participate in the Study as a Study site. The Institution assures that the Principal Investigator has sufficient authority, competence, and experience in clinical trials, as well as medical and scientific skills to participate in this Study, according to any legal and health applicable requirements. The Institution and the Principal Investigator will use their best efforts to recruit approximately . patients. The parties agree that the increase of the number of patients to be enrolled at the Institution will require written approval from the Sponsor, but not an amendment to this Agreement. Patient enrolment will stop when the total number of patients as specified in the Protocol has been recruited between participating sites.
Appears in 1 contract
Sources: Non Interventional Study Agreement